Haicui Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Haicui Wu has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
Li Dong
Shandong University of Traditional Chinese Medicine
8 shared publications- Fang Lian
Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, People’s Republic of China
6 shared publications Jiaxi Li
Shandong Wendeng Osteopathic Hospital
6 shared publicationsHsun-Ming Chang
Reproductive Medicine Center, Department of Obstetrics and Gynecology, China Medical University Hospital, Taichung, Taiwan
4 shared publicationsXin Xin
First School of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China
4 shared publications- Xin Xin
Guanghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
4 shared publications
Latest Publications
- Open Access
- 20 March 2026
- Published by Springer Nature in Basic and Clinical Andrology
- Vol. 36 (1) , 9
Association of sperm DNA fragmentation index with semen quality and ART outcomes: real-world evidence from a retrospective cohort
Background: Sperm DNA fragmentation index (DFI) has emerged as a potential marker of male fertility, but its clinical value in assisted reproductive technology (ART) remains debated. This study aimed to investigate the association between sperm DFI and conventional semen parameters, embryological outcomes, and pregnancy outcomes in ART, using a large real-world dataset. Results: A total of 1,784 ART cycles performed at a single center between January 2020 and January 2022 were analyzed. Patients were categorized into normal (< 30%) and high (≥ 30%) DFI groups. Compared with the normal DFI group, men with high DFI had significantly lower sperm concentration (B = − 31.15, 95% CI: − 44.75 to − 17.55), progressive motility (B = − 12.21, 95% CI: − 14.87 to − 9.56), and total motility (B = − 18.00, 95% CI: − 21.38 to − 14.62; all P < 0.001). After adjusting for female and male factors, high DFI was associated with a significantly lower 2PN fertilization rate (β = − 0.257, 95% CI: − 0.491 to − 0.024, P = 0.031), while no significant differences were observed in top-quality embryo rate, transferable embryo rate, or pregnancy outcomes. Sensitivity analyses using alternative statistical methods (ZOIB and PSM) and varying DFI thresholds (25% and 35%) yielded results completely consistent with the main analyses. Conclusions: High sperm DFI is independently associated with poorer semen quality and a reduced 2PN fertilization rate but was not significantly associated with embryo quality or pregnancy outcomes in this study. These findings support the clinical relevance of DFI in evaluating male fertility potential while suggesting its limited predictive value for ART success when female and cycle-related factors are considered.
- 20 March 2026
- Published by Springer Nature in Basic and Clinical Andrology
- Vol. 36 (1) , 9
Open AccessAssociation of sperm DNA fragmentation index with semen quality and ART outcomes: real-world evidence from a retrospective cohort
Background: Sperm DNA fragmentation index (DFI) has emerged as a potential marker of male fertility, but its clinical value in assisted reproductive technology (ART) remains debated. This study aimed to investigate the association between sperm DFI and conventional semen parameters, embryological outcomes, and pregnancy outcomes in ART, using a large real-world dataset. Results: A total of 1,784 ART cycles performed at a single center between January 2020 and January 2022 were analyzed. Patients were categorized into normal (< 30%) and high (≥ 30%) DFI groups. Compared with the normal DFI group, men with high DFI had significantly lower sperm concentration (B = − 31.15, 95% CI: − 44.75 to − 17.55), progressive motility (B = − 12.21, 95% CI: − 14.87 to − 9.56), and total motility (B = − 18.00, 95% CI: − 21.38 to − 14.62; all P < 0.001). After adjusting for female and male factors, high DFI was associated with a significantly lower 2PN fertilization rate (β = − 0.257, 95% CI: − 0.491 to − 0.024, P = 0.031), while no significant differences were observed in top-quality embryo rate, transferable embryo rate, or pregnancy outcomes. Sensitivity analyses using alternative statistical methods (ZOIB and PSM) and varying DFI thresholds (25% and 35%) yielded results completely consistent with the main analyses. Conclusions: High sperm DFI is independently associated with poorer semen quality and a reduced 2PN fertilization rate but was not significantly associated with embryo quality or pregnancy outcomes in this study. These findings support the clinical relevance of DFI in evaluating male fertility potential while suggesting its limited predictive value for ART success when female and cycle-related factors are considered.
- Open Access
- 30 December 2025
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 19 (1)
Erzhi Tiangui formula increases the number of high-quality blastocysts in patients with advanced age by regulating the Nrf2/HO-1 signaling pathway: a randomized controlled study
Oxidative stress (OS) is a significant challenge in the in vitro embryo culture of patients of advanced age. The Erzhi Tiangui (EZTG) formula has been show
- 30 December 2025
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 19 (1)
Open AccessErzhi Tiangui formula increases the number of high-quality blastocysts in patients with advanced age by regulating the Nrf2/HO-1 signaling pathway: a randomized controlled study
Oxidative stress (OS) is a significant challenge in the in vitro embryo culture of patients of advanced age. The Erzhi Tiangui (EZTG) formula has been show
- Open Access
- 12 December 2025
- Published by Taylor & Francis in Annals of Medicine
- Vol. 57 (1) , 2565437
Cellular senescence and polycystic ovary syndrome: mechanisms and therapeutic strategies from a new perspective
Cellular senescence is often linked to diseases or states of dysfunction, including reproductive disorders caused by ovarian dysfunction. It plays a significant role in conditions like polycystic ovary syndrome (PCOS). However, the specific effects and potential mechanisms of cellular senescence in PCOS need to be elucidated. This review comprehensively consolidates evidence from original research articles and systematic reviews to explore the association between PCOS and cellular senescence, particularly emphasizing cell senescence markers and mechanisms linked to various PCOS phenotypes. In addition, it also covers potential mechanisms and advances in cellular senescence-related treatment methods in PCOS. Current evidence suggests that cellular senescence might contribute to PCOS through mechanisms such as replicative senescence, stress-induced premature senescence, and immunoinflammatory responses mediated by senescent cells. Key features of senescence, including cell cycle arrest, the senescence-associated secretory phenotype (SASP), epigenetic changes, abnormal cell morphology, oxidative stress, DNA damage from telomere shortening and telomerase inhibition, and overactivation of anti-apoptotic pathways, are all related to PCOS. These mechanisms might especially impair follicular development in obese, hyperandrogenic, or insulin-resistant patients with PCOS, leading to endometrial hyporeceptivity and increased pregnancy complications. Senolytic and senomorphic drugs are valuable clinical treatments for PCOS respectively targeted to immune surveillance mechanisms of senescent cells or mitigated the harmful effects of senescent cells on intercellular communication. There is a complex correlation mechanism between cellular senescence and PCOS. Studying these cellular senescence markers and mechanisms in PCOS could provide new insights into the pathogenesis, and lay the groundwork for in-depth study and potential application of anti-senescence therapies in treating PCOS.
- 12 December 2025
- Published by Taylor & Francis in Annals of Medicine
- Vol. 57 (1) , 2565437
Open AccessCellular senescence and polycystic ovary syndrome: mechanisms and therapeutic strategies from a new perspective
Cellular senescence is often linked to diseases or states of dysfunction, including reproductive disorders caused by ovarian dysfunction. It plays a significant role in conditions like polycystic ovary syndrome (PCOS). However, the specific effects and potential mechanisms of cellular senescence in PCOS need to be elucidated. This review comprehensively consolidates evidence from original research articles and systematic reviews to explore the association between PCOS and cellular senescence, particularly emphasizing cell senescence markers and mechanisms linked to various PCOS phenotypes. In addition, it also covers potential mechanisms and advances in cellular senescence-related treatment methods in PCOS. Current evidence suggests that cellular senescence might contribute to PCOS through mechanisms such as replicative senescence, stress-induced premature senescence, and immunoinflammatory responses mediated by senescent cells. Key features of senescence, including cell cycle arrest, the senescence-associated secretory phenotype (SASP), epigenetic changes, abnormal cell morphology, oxidative stress, DNA damage from telomere shortening and telomerase inhibition, and overactivation of anti-apoptotic pathways, are all related to PCOS. These mechanisms might especially impair follicular development in obese, hyperandrogenic, or insulin-resistant patients with PCOS, leading to endometrial hyporeceptivity and increased pregnancy complications. Senolytic and senomorphic drugs are valuable clinical treatments for PCOS respectively targeted to immune surveillance mechanisms of senescent cells or mitigated the harmful effects of senescent cells on intercellular communication. There is a complex correlation mechanism between cellular senescence and PCOS. Studying these cellular senescence markers and mechanisms in PCOS could provide new insights into the pathogenesis, and lay the groundwork for in-depth study and potential application of anti-senescence therapies in treating PCOS.
- Open Access
- 1 September 2025
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 17, 2833-2844
The Impact of Age at First Sexual Intercourse on Female Reproductive Disorders: A Mendelian Randomized Study
Background: Female reproductive disorders (FRDs) are common diseases among women of childbearing age, affecting their reproductive health. Age at first sexual intercourse (AFS) is potentially linked to FRDs, and this study aims to investigate these associations and underlying mechanisms, to offer new insights and guidance for sex education in adolescent women and reproductive health management. Methods: Mendelian randomization (MR) analysis was performed using summary data from genome-wide association studies (GWASs). The AFS summary data were sourced from 397,338 European participants, and the outcome data were obtained from the FinnGen consortium. Additionally, multivariate MR (MVMR) and mediation analyses were also adopted to explore more detailed association. The MR results were rigorously validated, with the inverse variance weighted (IVW) method employed as the primary approach to assess causal relationships. Results: There is a significant causal relationship between AFS and ovarian dysfunction (OD), polycystic ovarian syndrome (PCOS), and spontaneous abortion (0.45 [0.25– 0.81], p=0.008; 0.35 [0.17– 0.74], p=0.006; 0.76 [0.63– 0.92], p=0.006). Among them, the genetic association between AFS and spontaneous abortion remained significant even after adjusting for more confounding variables (0.73 [0.55– 0.95], p=0.020; 0.76 [0.61– 0.95], p=0.015), and Body mass index (BMI) may be an important mediating factor in the association between AFS and PCOS (38.41%, p=7.17e-6) or OD (35.64%, p= 1.51e-6). Conclusion: Our research suggested that early AFS is closely associated with a higher risk of reproductive disorders, and timely interventions targeting BMI may partially alleviate the adverse effects of early sexual activity on reproductive health. The analysis based on genetic data emphasizes the importance of early sex education for adolescents, while weight management can to some extent avoid the occurrence of reproductive disorders during childbearing age, which also provide scientific basis for understanding the pathogenesis of FRDs and formulating appropriate reproductive health education strategies.
- 1 September 2025
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 17, 2833-2844
Open AccessThe Impact of Age at First Sexual Intercourse on Female Reproductive Disorders: A Mendelian Randomized Study
Background: Female reproductive disorders (FRDs) are common diseases among women of childbearing age, affecting their reproductive health. Age at first sexual intercourse (AFS) is potentially linked to FRDs, and this study aims to investigate these associations and underlying mechanisms, to offer new insights and guidance for sex education in adolescent women and reproductive health management. Methods: Mendelian randomization (MR) analysis was performed using summary data from genome-wide association studies (GWASs). The AFS summary data were sourced from 397,338 European participants, and the outcome data were obtained from the FinnGen consortium. Additionally, multivariate MR (MVMR) and mediation analyses were also adopted to explore more detailed association. The MR results were rigorously validated, with the inverse variance weighted (IVW) method employed as the primary approach to assess causal relationships. Results: There is a significant causal relationship between AFS and ovarian dysfunction (OD), polycystic ovarian syndrome (PCOS), and spontaneous abortion (0.45 [0.25– 0.81], p=0.008; 0.35 [0.17– 0.74], p=0.006; 0.76 [0.63– 0.92], p=0.006). Among them, the genetic association between AFS and spontaneous abortion remained significant even after adjusting for more confounding variables (0.73 [0.55– 0.95], p=0.020; 0.76 [0.61– 0.95], p=0.015), and Body mass index (BMI) may be an important mediating factor in the association between AFS and PCOS (38.41%, p=7.17e-6) or OD (35.64%, p= 1.51e-6). Conclusion: Our research suggested that early AFS is closely associated with a higher risk of reproductive disorders, and timely interventions targeting BMI may partially alleviate the adverse effects of early sexual activity on reproductive health. The analysis based on genetic data emphasizes the importance of early sex education for adolescents, while weight management can to some extent avoid the occurrence of reproductive disorders during childbearing age, which also provide scientific basis for understanding the pathogenesis of FRDs and formulating appropriate reproductive health education strategies.
- Open Access
- 17 June 2025
- Published by Wiley in Brain and Behavior
- Vol. 15 (6) , e70627
Association of Sleep, Inflammation and Female Infertility: A Cross‐Sectional Survey and Genetic Approach
Introduction: Inflammation has been implicated in both reproduction and sleep; however, the relationships remain unclear, and conclusive evidence for genetic associations is lacking.Methods: This study utilized the 2013–2020 National Health and Nutrition Examination Survey (NHANES) data and conducted a Mendelian randomization (MR) analysis to investigate the associations among inflammation, sleep, and female infertility. A cross‐sectional study was performed on 370 infertile women aged 20–44 years. Multiple linear regression was applied to evaluate the associations between sleep and the inflammatory markers. Subgroup and interaction analyses were conducted to assess the robustness of the findings. MR analysis was performed on 91 circulating inflammatory proteins, 11 sleep traits, and infertility to examine potential genetic associations.Results: A total of 370 infertile participants aged 20–44 years were included. The logarithmic platelet–lymphocyte ratio (PLR) was significantly higher in the sleep disorder group (p < 0.05). After adjusting for potential confounders, sleep disorders remained associated with a reduction in PLR (β = −0.145, 95% CI: −0.267 to −0.023, p < 0.05). MR analysis using the inverse variance weighted (IVW) method indicated that insomnia, subjective long sleep duration, and high sleep efficiency were associated with increased levels of oncostatin‐M, artemisinin, and adenosine deaminase, all of which are implicated in infertility. Additionally, the morning type was associated with increased levels of C‐X‐C motif chemokine 5, which reduced the risk of infertility.Conclusion: Sleep is associated with various inflammatory factors in the body and may contribute to infertility. Inflammation appears to play a key role in mediating the complex interplay between sleep and reproduction. These findings highlight the potential value of screening and managing specific inflammatory markers in infertile patients with sleep disorders to improve reproductive outcomes. However, further clinical studies and mechanistic experiments are needed to validate the genetic associations identified in this study.
- 17 June 2025
- Published by Wiley in Brain and Behavior
- Vol. 15 (6) , e70627
Open AccessAssociation of Sleep, Inflammation and Female Infertility: A Cross‐Sectional Survey and Genetic Approach
Introduction: Inflammation has been implicated in both reproduction and sleep; however, the relationships remain unclear, and conclusive evidence for genetic associations is lacking.Methods: This study utilized the 2013–2020 National Health and Nutrition Examination Survey (NHANES) data and conducted a Mendelian randomization (MR) analysis to investigate the associations among inflammation, sleep, and female infertility. A cross‐sectional study was performed on 370 infertile women aged 20–44 years. Multiple linear regression was applied to evaluate the associations between sleep and the inflammatory markers. Subgroup and interaction analyses were conducted to assess the robustness of the findings. MR analysis was performed on 91 circulating inflammatory proteins, 11 sleep traits, and infertility to examine potential genetic associations.Results: A total of 370 infertile participants aged 20–44 years were included. The logarithmic platelet–lymphocyte ratio (PLR) was significantly higher in the sleep disorder group (p < 0.05). After adjusting for potential confounders, sleep disorders remained associated with a reduction in PLR (β = −0.145, 95% CI: −0.267 to −0.023, p < 0.05). MR analysis using the inverse variance weighted (IVW) method indicated that insomnia, subjective long sleep duration, and high sleep efficiency were associated with increased levels of oncostatin‐M, artemisinin, and adenosine deaminase, all of which are implicated in infertility. Additionally, the morning type was associated with increased levels of C‐X‐C motif chemokine 5, which reduced the risk of infertility.Conclusion: Sleep is associated with various inflammatory factors in the body and may contribute to infertility. Inflammation appears to play a key role in mediating the complex interplay between sleep and reproduction. These findings highlight the potential value of screening and managing specific inflammatory markers in infertile patients with sleep disorders to improve reproductive outcomes. However, further clinical studies and mechanistic experiments are needed to validate the genetic associations identified in this study.
- 19 February 2025
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 51 (6) , 104870
NEAT1 inhibits granulosa cell apoptosis and promotes cell growth and migration through the miR-130a-3p/BMP6 axis
- 19 February 2025
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 51 (6) , 104870
NEAT1 inhibits granulosa cell apoptosis and promotes cell growth and migration through the miR-130a-3p/BMP6 axis
- Open Access
- 24 January 2025
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 42 (3) , 937-948
BMAL1 improves assisted reproductive technology outcomes in patients with polycystic ovary syndrome by targeting BMP6 and regulating ovarian granulosa cell apoptosis
Purpose To investigate BMAL1 and BMP6 expressive differences in ovarian granulosa cells (OGCs) of patients with polycystic ovary syndrome (PCOS), explore regulatory relationship, assess their impacts on OGC proliferation and apoptosis, and analyze their correlations with ART outcomes of patients. Methods A clinical study selected 40 PCOS patients who underwent IVF/ICSI in our hospital from January to October 2022 and 39 controls with male or tubal factor infertility. RT-qPCR and Western blot assessed BMAL1 and BMP6 mRNA/protein levels. The number of oocytes retrieved, 2PN fertilized oocytes, available embryos, and high-quality embryos were compared between groups and analyzed their correlations with BMAL1 and BMP6 expression levels. Cellular experiments were performed by overexpressing or knocking down BMAL1 in KGN cells by plasmid transfection. The dual-luciferase reporter assay was used to identify BMAL1/BMP6 regulatory relationship. CCK-8 and flow cytometry assessed cellular proliferation and apoptosis. Results BMAL1 mRNA/protein expression (P < 0.001) in the PCOS group was significantly lower than that in controls, as was the number of high-quality embryos (P = 0.001). Contrastingly, BMP6 (P < 0.001) was significantly higher in the PCOS group. BMAL1 expression levels were negatively correlated with BMP6 (r = − 0.684, P = 0.002) and positively correlated with the number of 2PN fertilized oocytes, available embryos, and high-quality embryos (r = 0.659, P = 0.003; r = 0.623, P = 0.006; and r = 0.738, P < 0.001). Cellular experiments showed that overexpression of BMAL1 significantly decreased relative luciferase activity (P < 0.01). Overexpression of BMAL1 significantly decreased KGN cell apoptosis (P < 0.01) and enhanced proliferation (P < 0.01). Conclusion BMAL1 regulates OGCs proliferation and apoptosis by targeting BMP6, thereby influencing ART outcomes in patients with PCOS. This study might provide molecular factors that indicate ART outcomes and therapeutic targets for PCOS. Trial registration Registration number: ChiCTR2100052331; registration date: 2021–10-24.
- 24 January 2025
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 42 (3) , 937-948
Open AccessBMAL1 improves assisted reproductive technology outcomes in patients with polycystic ovary syndrome by targeting BMP6 and regulating ovarian granulosa cell apoptosis
Purpose To investigate BMAL1 and BMP6 expressive differences in ovarian granulosa cells (OGCs) of patients with polycystic ovary syndrome (PCOS), explore regulatory relationship, assess their impacts on OGC proliferation and apoptosis, and analyze their correlations with ART outcomes of patients. Methods A clinical study selected 40 PCOS patients who underwent IVF/ICSI in our hospital from January to October 2022 and 39 controls with male or tubal factor infertility. RT-qPCR and Western blot assessed BMAL1 and BMP6 mRNA/protein levels. The number of oocytes retrieved, 2PN fertilized oocytes, available embryos, and high-quality embryos were compared between groups and analyzed their correlations with BMAL1 and BMP6 expression levels. Cellular experiments were performed by overexpressing or knocking down BMAL1 in KGN cells by plasmid transfection. The dual-luciferase reporter assay was used to identify BMAL1/BMP6 regulatory relationship. CCK-8 and flow cytometry assessed cellular proliferation and apoptosis. Results BMAL1 mRNA/protein expression (P < 0.001) in the PCOS group was significantly lower than that in controls, as was the number of high-quality embryos (P = 0.001). Contrastingly, BMP6 (P < 0.001) was significantly higher in the PCOS group. BMAL1 expression levels were negatively correlated with BMP6 (r = − 0.684, P = 0.002) and positively correlated with the number of 2PN fertilized oocytes, available embryos, and high-quality embryos (r = 0.659, P = 0.003; r = 0.623, P = 0.006; and r = 0.738, P < 0.001). Cellular experiments showed that overexpression of BMAL1 significantly decreased relative luciferase activity (P < 0.01). Overexpression of BMAL1 significantly decreased KGN cell apoptosis (P < 0.01) and enhanced proliferation (P < 0.01). Conclusion BMAL1 regulates OGCs proliferation and apoptosis by targeting BMP6, thereby influencing ART outcomes in patients with PCOS. This study might provide molecular factors that indicate ART outcomes and therapeutic targets for PCOS. Trial registration Registration number: ChiCTR2100052331; registration date: 2021–10-24.
- Open Access
- 7 December 2024
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 42 (2) , 389-403
Role of epigenetic regulation in diminished ovarian reserve
Diminished ovarian reserve (DOR) is characterized by a decrease in the number and quality of oocytes, with its incidence increasing annually. Its pathogenesis remains unclear, making it one of the most challenging problems in the field of assisted reproduction. Epigenetic modification, a molecular mechanism affecting genomic activity and expression without altering the DNA sequence, has been widely studied in reproductive medicine and has attracted considerable attention regarding DOR. This review comprehensively examines the various epigenetic regulatory changes in ovarian granulosa cells (OGCs) and oocytes during DOR. DNA methylation plays a crucial role in regulating granulosa cell function, hormone production, and oocyte development, maturation, and senescence. Histone modifications are involved in regulating follicular activation, while non-coding RNAs, such as long noncoding RNAs (lncRNAs) and microRNAs (miRNAs), regulate granulosa cell function and oocyte development. N6-methyladenosine (m6A) modifications are associated with age-related oocyte senescence. Epigenetic clocks based on DNA methylation show potential in predicting ovarian reserve in DOR. Furthermore, it discusses the potential for utilizing epigenetic mechanisms to better diagnose and manage DOR.
- 7 December 2024
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 42 (2) , 389-403
Open AccessRole of epigenetic regulation in diminished ovarian reserve
Diminished ovarian reserve (DOR) is characterized by a decrease in the number and quality of oocytes, with its incidence increasing annually. Its pathogenesis remains unclear, making it one of the most challenging problems in the field of assisted reproduction. Epigenetic modification, a molecular mechanism affecting genomic activity and expression without altering the DNA sequence, has been widely studied in reproductive medicine and has attracted considerable attention regarding DOR. This review comprehensively examines the various epigenetic regulatory changes in ovarian granulosa cells (OGCs) and oocytes during DOR. DNA methylation plays a crucial role in regulating granulosa cell function, hormone production, and oocyte development, maturation, and senescence. Histone modifications are involved in regulating follicular activation, while non-coding RNAs, such as long noncoding RNAs (lncRNAs) and microRNAs (miRNAs), regulate granulosa cell function and oocyte development. N6-methyladenosine (m6A) modifications are associated with age-related oocyte senescence. Epigenetic clocks based on DNA methylation show potential in predicting ovarian reserve in DOR. Furthermore, it discusses the potential for utilizing epigenetic mechanisms to better diagnose and manage DOR.
- Open Access
- 11 November 2024
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 17 (1) , 1-13
Exploring lncRNA expression in follicular fluid exosomes of patients with obesity and polycystic ovary syndrome based on high-throughput sequencing technology
Infertility is a reproductive health problem that attracts worldwide attention. Polycystic ovary syndrome (PCOS) is a major cause of female infertility and patients with obesity and PCOS are particularly common in clinical practice. Long non-coding RNA (lncRNAs) are a functional core in cells that regulate gene expression, transcription, and chromatin modification processes, and participate in epigenetics, cell cycle, and cell differentiation. LncRNAs are assumed to play a role in the occurrence and development of PCOS; however, their specific mechanism of action remains to be elucidated. High-throughput sequencing technology has been used to sequence and analyze lncRNAs in exosomes from the follicular fluid of patients with obesity and PCOS and those who underwent assisted reproductive therapy owing to male factors. Specific expression profiles of patients with obesity and PCOS were obtained and functional information analysis combined with a literature review were performed to screen for differentially expressed lncRNAs, which were validated using real-time reverse transcription quantitative polymerase chain reaction (RT-qPCR). High-throughput sequencing analysis revealed that compared to normal patients with male infertility, patients with obesity and PCOS had a total of 20 lncRNAs with significant expression differences in follicular fluid exosomes. Among them, 17 lncRNAs were upregulated and three were downregulated. Functional analysis showed that differentially expressed genes were mainly enriched in “cell metabolism,” “cell adhesion,” and other aspects: related gene pathways mainly involved Huntington’s disease, Parkinson’s disease, spliceosomes, non-alcoholic fatty liver disease, and ribosomes. Verification of differentially expressed lncRNAs revealed that the expression of lncRNAs TPT1-AS1, PTOV1-AS1, PTPRG-AS1, and SNHG14 in follicular fluid exosomes was consistent with the sequencing results. A preliminary differential expression profile of lncRNAs in exosomes of patients with obesity and PCOS was established by transcriptomic analysis of these individuals. Our bioinformatics analysis results may be applicable to further study of the impact mechanism involving obesity and PCOS. These differentially expressed lncRNAs maybe served as potential biomarkers for in-depth studies of the occurrence, development on Follicle quality and function for patients with PCOS in the future.
- 11 November 2024
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 17 (1) , 1-13
Open AccessExploring lncRNA expression in follicular fluid exosomes of patients with obesity and polycystic ovary syndrome based on high-throughput sequencing technology
Infertility is a reproductive health problem that attracts worldwide attention. Polycystic ovary syndrome (PCOS) is a major cause of female infertility and patients with obesity and PCOS are particularly common in clinical practice. Long non-coding RNA (lncRNAs) are a functional core in cells that regulate gene expression, transcription, and chromatin modification processes, and participate in epigenetics, cell cycle, and cell differentiation. LncRNAs are assumed to play a role in the occurrence and development of PCOS; however, their specific mechanism of action remains to be elucidated. High-throughput sequencing technology has been used to sequence and analyze lncRNAs in exosomes from the follicular fluid of patients with obesity and PCOS and those who underwent assisted reproductive therapy owing to male factors. Specific expression profiles of patients with obesity and PCOS were obtained and functional information analysis combined with a literature review were performed to screen for differentially expressed lncRNAs, which were validated using real-time reverse transcription quantitative polymerase chain reaction (RT-qPCR). High-throughput sequencing analysis revealed that compared to normal patients with male infertility, patients with obesity and PCOS had a total of 20 lncRNAs with significant expression differences in follicular fluid exosomes. Among them, 17 lncRNAs were upregulated and three were downregulated. Functional analysis showed that differentially expressed genes were mainly enriched in “cell metabolism,” “cell adhesion,” and other aspects: related gene pathways mainly involved Huntington’s disease, Parkinson’s disease, spliceosomes, non-alcoholic fatty liver disease, and ribosomes. Verification of differentially expressed lncRNAs revealed that the expression of lncRNAs TPT1-AS1, PTOV1-AS1, PTPRG-AS1, and SNHG14 in follicular fluid exosomes was consistent with the sequencing results. A preliminary differential expression profile of lncRNAs in exosomes of patients with obesity and PCOS was established by transcriptomic analysis of these individuals. Our bioinformatics analysis results may be applicable to further study of the impact mechanism involving obesity and PCOS. These differentially expressed lncRNAs maybe served as potential biomarkers for in-depth studies of the occurrence, development on Follicle quality and function for patients with PCOS in the future.
- RetractedOpen Access
- 24 March 2024
- Published by Wiley in International Wound Journal
- Vol. 21 (4) , e14740
RETRACTED: Effect of prophylactic use of cefazolin in caesarean section on postoperative infection: A meta‐analysis
Caesarean section rate is increasing and postoperative wound infection is a major health‐threatening complication after caesarean section (CS). The aim of this study was to evaluate the efficacy of Cefazolin at different time for post‐caesarean delivery. The aim of this study was to compare the use of Cefazolin at different times on infections after CS. The time of antibiotic use in CS can be divided into two groups: before skin incision (SI) and after cord clamping (CC). In this study, 268 relevant articles were found in the database, and finally, 10 articles were analysed. This study included a total of 5256 cases of caesarean section. The data on wound infections, endometritis, urinary tract infections and fever were analysed. Perform an analysis of the data using RevMan 5.3. The results showed that cefazolin before SI reduced wound infection compared to after CC (odds ratio [OR], 0.51; 95% CI: 0.37–0.69; p < 0.0001). Cefazolin prophylactically used before SI reduce endometritis after CS compared to after CC (OR, 0.52; 95% CI: 0.35–0.77; p = 0.001). There was no significant difference in urinary tract infections after CS between cefazolin prophylactically used before SI and after CC (OR, 0.80; 95% CI: 0.50–11.28; p = 0.35). There was no significant difference in fever after CS between the prophylactic use of cefazolin before SI and after CC (OR, 0.60; 95% CI: 0.26–11.43; p = 0.225). Cefazolin before SI reduces wound infection and endometritis after CS.
- 24 March 2024
- Published by Wiley in International Wound Journal
- Vol. 21 (4) , e14740
RetractedOpen AccessRETRACTED: Effect of prophylactic use of cefazolin in caesarean section on postoperative infection: A meta‐analysis
Caesarean section rate is increasing and postoperative wound infection is a major health‐threatening complication after caesarean section (CS). The aim of this study was to evaluate the efficacy of Cefazolin at different time for post‐caesarean delivery. The aim of this study was to compare the use of Cefazolin at different times on infections after CS. The time of antibiotic use in CS can be divided into two groups: before skin incision (SI) and after cord clamping (CC). In this study, 268 relevant articles were found in the database, and finally, 10 articles were analysed. This study included a total of 5256 cases of caesarean section. The data on wound infections, endometritis, urinary tract infections and fever were analysed. Perform an analysis of the data using RevMan 5.3. The results showed that cefazolin before SI reduced wound infection compared to after CC (odds ratio [OR], 0.51; 95% CI: 0.37–0.69; p < 0.0001). Cefazolin prophylactically used before SI reduce endometritis after CS compared to after CC (OR, 0.52; 95% CI: 0.35–0.77; p = 0.001). There was no significant difference in urinary tract infections after CS between cefazolin prophylactically used before SI and after CC (OR, 0.80; 95% CI: 0.50–11.28; p = 0.35). There was no significant difference in fever after CS between the prophylactic use of cefazolin before SI and after CC (OR, 0.60; 95% CI: 0.26–11.43; p = 0.225). Cefazolin before SI reduces wound infection and endometritis after CS.